Home » Newsletters » BioWorld Science

BioWorld Science

May 3, 2005

View Archived Issues

Kynurenine 3-monooxygenase: a therapeutic target for Huntington disease

ZK-EPO active against bone metastases in breast cancer

Promising results reported with a lingual spray formulation of alprazolam

Data from the HERA study support the use of Herceptin in early breast cancer

Updated survival data reported from phase I study of IL13-PE38QQR

Phase I gene therapy study for Parkinson's nears completion

ImmuFact IMP-321 enters phase I/II trials

Elixir licenses growth hormone secretagogue from BMS

GSK will not negotiate HER-2 Protein AutoVac vaccine deal

Seattle Genetics and MedImmune form antibody-drug conjugate collaboration

Semafore presents new in vivo data on SF-1126

Model proposed to explain the species-specific effects of SB-497115

Cranberry juice constituents display antiinfluenza potential

EP-2306 and EP-2302 demonstrate lipid-lowering potential in vitro

Update on the efficacy of rosuvastatin in hypercholesterolemia

Triglyceride levels have no effect on the benefits of rimonabant in overweight/obese patients

A drospirenone/estradiol combination decreases blood pressure in high-risk hypertensive women

Prous Science presents key webcast coverage of the 96th Annual Meeting of the AACR

FDA approval for Byetta

Zostavax BLA submission

Celera Genomics submits IND for CRA-024781

Supplemental NDA filed for Tarceva in pancreatic cancer

Fatty acids improve visual function in infants

Novel antiinfective agents claimed in recent patent literature

New treatments for hepatitis disclosed by Genelabs and Enanta

Recent patents describe new treatments for respiratory disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...